Sperm Health and Natural Support

Evidence-based nutrition and supplement approaches to improving sperm count, motility, and morphology — including CoQ10, ashwagandha, selenium, and omega-3 fatty acids

Sperm quality is declining significantly — a 2017 meta-analysis of 185 studies found that sperm counts in Western men dropped by more than 50% between 1973 and 2011. [1] For couples trying to conceive, and for men who want to optimise long-term reproductive and hormonal health, diet and targeted supplementation can meaningfully improve the key measures: sperm count, motility, and morphology. The primary driver of sperm damage is oxidative stress within the reproductive tract, which can be directly countered through antioxidants and supportive nutrients. CoQ10 significantly improved sperm density and motility in a 212-man placebo-controlled trial. [2] Ashwagandha root extract increased sperm count by 167% in a pilot RCT in oligospermic men. [3] Zinc, selenium, omega-3 fatty acids, and vitamin E each address distinct vulnerabilities in sperm development and structural integrity. [4][5][6]

Why Sperm Quality Matters — and What Can Go Wrong

Human sperm cells are unusually defenceless against oxidative stress. Unlike most cells, mature sperm shed most of their cytoplasm — and with it, most of their antioxidant enzymes — during the final stages of formation. What remains is a cell whose plasma membrane is approximately 60% polyunsaturated fatty acids (predominantly DHA), making it highly vulnerable to lipid peroxidation. A single bout of oxidative damage can cause the sperm's DNA to fragment, its tail to lose motility, or its head membrane to become too rigid to penetrate an egg.

Oxidative stress in semen can come from chronic inflammation, heat exposure (laptops on laps, hot baths, tight underwear), smoking, heavy alcohol intake, environmental toxin exposure (phthalates, pesticides, BPA), poor sleep, and nutritional deficiencies — particularly low zinc, selenium, vitamin C, and vitamin E.

The three parameters that most predict male fertility potential are:

Sperm count (concentration per millilitre of semen; normal ≥16 million/mL by WHO 2021 criteria)
Total motility (percentage of sperm actively swimming; normal ≥42%)
Morphology (normal form by Kruger strict criteria; normal ≥4%)

A man can have low count but acceptable motility, acceptable count but poor morphology, or all three impaired simultaneously. The interventions below target different aspects of sperm biology and are most useful in combination.

CoQ10: Energising the Sperm Tail

Coenzyme Q10 is a fat-soluble antioxidant and a critical component of the mitochondrial electron transport chain. Sperm motility depends entirely on ATP generated by mitochondria packed into the midpiece of the sperm tail — without abundant ATP, the flagellum cannot beat with sufficient force to swim forward progressively. CoQ10 levels in seminal plasma directly correlate with sperm motility in both fertile and infertile men.

As an antioxidant, CoQ10 also scavenges free radicals within the reproductive tract before they damage sperm membranes and DNA. The clinical dose used in trials is 200–300 mg/day of ubiquinone, or 100–200 mg of the more bioavailable ubiquinol form. Allow 3–6 months — a full sperm cycle takes approximately 74 days (spermatogenesis) plus epididymal transit time. [2]

Ashwagandha: Hormonal and Spermatogenic Support

Ashwagandha (Withania somnifera) increases sperm count through at least two mechanisms: it normalises cortisol and reduces chronic HPA-axis overactivation (which suppresses LH and testosterone), and it appears to directly stimulate spermatogenesis through adaptogenic effects on the gonadal axis. Testosterone increased by 17% and LH by 34% in men taking ashwagandha in clinical studies. [3]

Chronic psychological stress suppresses gonadotropin-releasing hormone (GnRH) from the hypothalamus, reducing LH and FSH output and thereby reducing both testosterone production and spermatogenesis. Ashwagandha's cortisol-lowering effects likely contribute substantially to its reproductive outcomes. The clinical dose in studies is 675 mg/day of root extract (standardised to withanolide content), often divided into three 225 mg doses. KSM-66 is the most clinically studied branded extract.

See our ashwagandha page for its broader adaptogenic applications.

Zinc and Selenium: Structural Building Blocks

Zinc is the most abundant trace element in the male reproductive tract. It is essential for testosterone synthesis, sperm maturation in the epididymis, and the structural integrity of sperm chromatin (the tightly packaged DNA inside the sperm head). Seminal plasma zinc concentrations are consistently lower in infertile men than fertile controls, and zinc deficiency leads to reduced testosterone, lower sperm count, and impaired morphology.

Selenium is incorporated into selenoprotein P and into a mitochondrial capsule protein that forms part of the sperm tail's structural apparatus. Without adequate selenium, the tail develops structural abnormalities and sperm cannot swim properly. Selenium and vitamin E work synergistically — vitamin E prevents the lipid peroxidation that would otherwise destroy the selenium-containing proteins before they are assembled into sperm structure. [4][5]

Food sources for zinc: oysters (richest source), red meat, pumpkin seeds, and eggs. For selenium: Brazil nuts (one to three per day provides ~70–240 mcg), seafood, and organ meats. Supplemental doses in clinical trials: zinc 25–66 mg/day, selenium 200 mcg/day. Excess selenium (above 400 mcg/day) is toxic — stay within the safe range.

Omega-3 Fatty Acids: Membrane Fluidity and the Acrosomal Reaction

DHA constitutes approximately 60% of total polyunsaturated fatty acids in human spermatozoa. It is concentrated in the sperm head membrane, where it maintains the membrane fluidity required for capacitation (the maturation step that occurs in the female reproductive tract) and the acrosomal reaction — the enzyme-releasing process by which a sperm penetrates and fertilises an egg. DHA-deficient sperm show abnormal morphology and reduced motility regardless of sperm count. [6]

Sources: oily fish (wild salmon, mackerel, sardines, herring), or algal oil supplements for those avoiding fish. Algal DHA is the direct source fish accumulate it from — bioequivalent and free of mercury. Aim for 1–2 grams of combined EPA+DHA daily.

See our omega-3 page and wild salmon page for food-first approaches.

Lifestyle Factors That Matter

Heat: Sperm production requires scrotal temperature 2–3°C below core body temperature. Sustained heat from laptop use, prolonged sitting, hot baths, or tight underwear impairs spermatogenesis. Allow 3 months after removing the heat source to see improvement — the time needed for one full sperm cycle.

Sleep: Testosterone is produced predominantly during slow-wave sleep. Men consistently sleeping under 6 hours per night show lower testosterone and reduced sperm quality compared to those sleeping 7–8 hours.

Alcohol: Heavy intake suppresses LH and testosterone and directly damages testicular tissue. The effect is largely reversible within 3 months of cessation or significant reduction.

Smoking: Cigarette smoke directly generates reactive oxygen species in seminal fluid, damages sperm DNA, and reduces count and motility in a dose-dependent fashion that is largely reversible within 3–6 months of stopping.

Environmental toxins: Phthalates, BPA, organophosphate pesticides, and heavy metals disrupt male reproductive hormones by acting as endocrine disruptors. Reducing exposure through glass food storage, filtered water, and reduced processed food intake meaningfully lowers cumulative burden. See our phthalates page and BPA page.

Evidence Review

The Declining Sperm Count: Levine et al. (2017)

Levine et al. (2017) conducted a systematic review and meta-regression analysis of 185 studies on sperm count trends from 1973 to 2011, representing data from 42,935 men across 50 countries. [1] The analysis focused specifically on unselected men — not recruited from fertility clinics — to avoid ascertainment bias.

Key findings:

Sperm concentration fell by 52.4% (95% CI: 37.8–63.3%) in men from North America, Europe, Australia, and New Zealand
Total sperm count declined by 59.3% (95% CI: 43.4–71.0%) in the same population
The decline showed no sign of levelling off through 2011
A 2022 updated analysis expanded the finding globally and found the rate of decline was accelerating post-2000

The magnitude of this decline — more than half of sperm count in 40 years — is one of the most striking epidemiological trends in modern reproductive medicine. The proposed drivers include rising obesity, endocrine-disrupting chemical exposure (phthalates, pesticides, BPA, PFAS), increased sedentary behaviour, chronic stress, reduced sleep quality, and dietary changes toward ultra-processed foods. This is not a genetic change — the timeframe is too short. It represents an environmental and behavioural phenotype, meaning the factors driving it are substantially modifiable.

The clinical implication is that the average Western man today has substantially lower sperm counts than his grandfather, making optimisation of the modifiable factors described in this page more clinically relevant than at any prior point in modern history.

CoQ10 RCT: Safarinejad (2009)

Safarinejad (2009) conducted a randomised, double-blind, placebo-controlled trial in 212 infertile men with idiopathic oligoasthenoteratozoospermia — simultaneously low count, poor motility, and abnormal morphology of unknown cause, the most common diagnosis in male infertility workups. [2] 106 men received 300 mg CoQ10 (ubiquinone) daily; 106 received matching placebo for 26 weeks, followed by a 30-week treatment-free observation phase.

Primary results at 26 weeks:

Sperm density: significant improvement in the CoQ10 group vs. placebo (p=0.01)
Sperm motility: significant improvement (p=0.01)
Morphology (Kruger criteria): increase in normal forms in CoQ10 group (p=0.07, approaching significance)
Seminal CoQ10 levels: significantly increased in the treatment group

FSH and inhibin B — hormonal markers of spermatogenesis efficiency — moved in the expected direction with CoQ10 treatment, supporting a genuine spermatogenic effect rather than a purely antioxidant one. During the treatment-free follow-up, benefits were partially maintained, then gradually reversed.

Limitations: idiopathic infertility is a heterogeneous diagnosis and the trial does not identify which subgroup benefits most. Pregnancy rates were not a primary outcome in this design. A 2024 meta-analysis of CoQ10 RCTs confirmed the finding of significant improvements in sperm concentration, motility, and pregnancy odds, lending additional weight to the single-trial result.

Ashwagandha Pilot RCT: Ambiye et al. (2013)

Ambiye et al. (2013) enrolled 46 men with oligospermia (sperm count below 20 million/mL) in a double-blind, placebo-controlled pilot trial. [3] 21 received 675 mg of full-spectrum ashwagandha root extract daily (225 mg three times daily); 25 received placebo for 90 days.

Results at 90 days:

Sperm count: 167% increase in ashwagandha group vs. 13% in placebo (p<0.001)
Semen volume: 53% increase vs. 10% in placebo (p<0.001)
Sperm motility: 57% increase vs. 4% in placebo (p<0.001)
Serum testosterone: 17% increase vs. approximately zero in placebo
LH: 34% increase, consistent with increased central gonadotrophin drive

These effect sizes are unusually large for a supplement intervention. The magnitude of the sperm count increase likely reflects a combination of direct spermatogenic effects and correction of HPA-axis dysregulation: chronically elevated cortisol suppresses GnRH from the hypothalamus, reducing downstream LH and FSH, which in turn depresses testosterone production and spermatogenesis. Ashwagandha's well-documented cortisol-lowering effects are expected to reverse this suppression, potentially explaining a significant portion of the fertility benefit.

Limitations: small sample size (n=46), single pilot trial, and men with pathologically low baseline counts (who have the most room to improve proportionally). Replication in larger trials is needed before this finding should be considered definitive. However, the biological mechanism is credible and the effect size is large enough that even a partial replication would be clinically meaningful.

Salas-Huetos Meta-Analysis: Nutrients and Sperm Quality (2018)

Salas-Huetos et al. (2018) conducted a systematic review and meta-analysis of 28 randomised clinical trials examining the effect of dietary supplements and individual nutrients on sperm quality parameters. [4] This is the most comprehensive quantitative overview of the evidence base.

Selected findings from pooled analyses:

Zinc: significantly increased sperm concentration (+1.48 × 10⁶ sperm/mL) and total motility (+7.03%)
Selenium: significantly increased sperm concentration (+3.91 × 10⁶ sperm/mL) and total motility (+3.30%)
Omega-3 fatty acids: significant positive effect on motility across included trials
Antioxidant combinations: consistently improved at least one sperm parameter across most trials

The review noted substantial heterogeneity across studies — varying doses, durations (ranging from 3 weeks to 6 months), different populations (fertile versus infertile men), and inconsistent outcome definitions make direct comparison across trials difficult. The overall conclusion is that antioxidant and micronutrient supplementation has meaningful impact on sperm quality, with the most consistent effects for zinc, selenium, CoQ10, and combined antioxidant protocols.

Selenium and Vitamin E: Moslemi and Tavanbakhsh (2011)

Moslemi and Tavanbakhsh (2011) studied 690 infertile men with idiopathic asthenoteratospermia who received daily selenium 200 mcg plus vitamin E 400 IU for a minimum of 10 weeks — one of the largest single-intervention studies in this area. [5]

Results:

52.6% of men showed significant improvement in sperm motility, morphology, or both
10.8% of couples achieved spontaneous pregnancy during or after the supplementation period

The combination of selenium and vitamin E is mechanistically coherent: selenium is required structurally for the selenoproteins that protect sperm membranes and form part of the tail apparatus, while vitamin E (a lipid-soluble antioxidant) protects the DHA-rich sperm membrane from lipid peroxidation. The two nutrients address different aspects of the same vulnerability (membrane integrity) and are therefore synergistic. A spontaneous pregnancy rate of 10.8% in a population diagnosed with infertility — without IVF or IUI — is clinically notable.

Limitations: this was an open-label study without a placebo control, making it impossible to fully attribute outcomes to the intervention. Background pregnancy rates in couples with male-factor infertility are typically 1–5% per year without treatment, so the 10.8% figure over the study period is likely above natural background, but a controlled comparison would be required to confirm this definitively.

Omega-3 Fatty Acids and Semen Quality: Falsig et al. (2019)

Falsig, Gleerup, and Knudsen (2019) conducted a systematic PRISMA review of 16 studies examining omega-3 fatty acids and semen quality markers, including both observational studies and randomised controlled trials. [6]

Key findings:

DHA constitutes approximately 60% of total polyunsaturated fatty acids in human spermatozoa — the highest concentration of any fatty acid in sperm
Higher sperm DHA is positively associated with motility, morphology, and concentration in observational studies
In RCTs: 3 of 4 trials showed improvement in at least one fertility marker with omega-3 supplementation (primarily DHA or EPA+DHA)
The most consistent benefit was for sperm motility; effects on morphology and concentration were more variable

DHA is essential for the lateral membrane fluidity of the sperm head required for capacitation and the acrosomal reaction. DHA-deficient sperm show abnormal morphology (bent tails, misshaped heads) and reduced motility irrespective of sperm count. The lag between improving dietary DHA intake and observing changes in sperm quality is approximately 2–3 months — corresponding to the time required for the current cohort of maturing spermatids to incorporate the available DHA into their membranes.

Practical Evidence Integration

The evidence stratifies across these interventions:

Best established (multiple RCTs, meta-analysis confirmation):

CoQ10 — significant improvement in count and motility in 26-week RCT of 212 men; confirmed by subsequent meta-analysis [2][4]
Zinc and selenium — consistent improvements across multiple RCTs in pooled analysis [4][5]

Promising (strong single RCT with large effect, credible biological mechanism):

Ashwagandha — 167% sperm count increase in pilot RCT, with hormonal mechanism via cortisol and LH normalisation [3]

Consistent observational evidence with supporting RCT data:

Omega-3/DHA — structural role in sperm membrane well established; RCT evidence predominantly positive for motility [6]

A comprehensive approach for men with known sperm quality concerns would include CoQ10 (200–300 mg/day), zinc (25–50 mg/day), selenium (200 mcg/day), omega-3s (1–2 g EPA+DHA/day), vitamin E (200–400 IU/day), and ashwagandha where stress is a contributing factor (675 mg/day of standardised extract). Allow a minimum of 3–6 months before evaluating response — improvements in sperm quality follow the 74-day spermatogenesis timeline and cannot be detected meaningfully in shorter periods.

References

Temporal trends in sperm count: a systematic review and meta-regression analysisLevine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Mindlis I, Pinotti R, Swan SH. Human Reproduction Update, 2017. PubMed 28981654 →
Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile menSafarinejad MR. Journal of Urology, 2009. PubMed 19447425 →
Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha (Withania somnifera) in Oligospermic Males: A Pilot StudyAmbiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Evidence-Based Complementary and Alternative Medicine, 2013. PubMed 24371462 →
The Effect of Nutrients and Dietary Supplements on Sperm Quality Parameters: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsSalas-Huetos A, Bulló M, Salas-Salvadó J. Advances in Nutrition, 2018. PubMed 30462179 →
Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rateMoslemi MK, Tavanbakhsh S. International Journal of General Medicine, 2011. PubMed 21403799 →
The influence of omega-3 fatty acids on semen quality markers: a systematic PRISMA reviewFalsig AL, Gleerup CS, Knudsen UB. Andrology, 2019. PubMed 31116515 →